Document is current
Any future updates will be listed below
-
Authors
Hartmann, Lennart M. https://orcid.org/0000-0002-8762-9340
Boemer, Franziska
Hillenmayer, Anna
Wolf, Armin
Wertheimer, Christian M.
-
Funding
Funding for this research was provided by:
Universität Ulm
- License Information
-
More Information
Article History
Received: 15 March 2025
Revised: 6 May 2025
Accepted: 9 June 2025
First Online: 28 June 2025
Ethics approval
: This study was approved by the responsible Ethics Committee (ethical approval ID: 22/24) and conducted in accordance with the tenets of the declaration of Helsinki.
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the responsible Ethics Committee with the need for written informed consent waived.
: Prof. Dr. Armin Wolf received research grants and study fees from Allergan, Boehringer Ingelheim, Bayer, Alimera, Novartis, Oertli and Roche and consulting honoraria and travel fees from Alimera, Allergan, Bayer, Boehringer Ingelheim, Novartis, Oertli, Roche and Zeiss. Lennart Hartmann received speaker fees from Bayer. Anna Hillenmayer received speaker fees from Bayer and Novartis. All of these are not connected to this article. For the remaining authors none conflict of interests or fundings were declared.
